Glucagen

Glucagen is a prescription medication that contains the active ingredient glucagon. It is supplied as an injectable preparation for intramuscular, intravenous, or subcutaneous administration. Marketed in the European Union, Glucagen is used under medical supervision to raise blood glucose levels when rapid correction is needed. The product can be prepared in various concentrations as directed by a healthcare professional for the patient according to clinical guidelines.

Glucagen is indicated for several acute medical situations where rapid elevation of blood glucose is required.

- Treatment of severe hypoglycemia in patients with diabetes when oral glucose is not feasible. - Emergency management of beta‑blocker or calcium‑channel blocker overdose. - Diagnostic use in the glucagon stimulation test to assess growth hormone deficiency. - Supportive therapy during certain cardiac stress tests where glucose modulation is needed. - Adjunct in some protocols for assessing adrenal insufficiency. - Use in pediatric patients for congenital hyperinsulinism when other therapies are ineffective.

Glucagen may cause a range of physiological responses after administration, varying from mild to severe. These effects are generally short‑lived and resolve without intervention in most individuals.

Common: - Nausea or vomiting. - Flushing or warmth sensation. - Transient headache. - Mild abdominal discomfort. - Dizziness or light‑headed feeling. - Transient increase in blood pressure. - Mild tremor or shakiness. - Temporary feeling of anxiety.

Serious: - Severe allergic reaction (anaphylaxis) with rash, swelling, or difficulty breathing. - Rapid heart rhythm disturbances (arrhythmia) or chest pain. - Hypotension or shock in rare cases. - Seizure activity in patients with pre‑existing neurological disorders. - Severe hyperglycemia if dose is excessive. - Cardiovascular collapse in patients with underlying heart disease.

When prescribing or administering Glucagen, clinicians should observe several precautionary measures to ensure patient safety.

- Verify the diagnosis of hypoglycemia or other indication before use. - Assess for known hypersensitivity to glucagon or any formulation components. - Use the lowest effective dose and monitor blood glucose closely after administration. - Exercise caution in patients with pheochromocytoma, adrenal insufficiency, or cardiovascular disease. - Avoid use in pregnant or nursing women unless the benefit outweighs the risk, as safety data are limited. - Ensure proper storage away from light and at recommended temperatures to maintain potency.

Glucagen can interact with other agents, influencing its efficacy or safety profile.

Avoid: - Concomitant use with beta‑adrenergic antagonists that may mask glucagon’s cardiovascular effects. - Administration alongside insulin analogs without appropriate glucose monitoring. - Avoid use in patients receiving high-dose catecholamines, as response may be unpredictable.

Use with caution: - Use with other vasopressors; monitor blood pressure closely. - Caution when combined with oral hypoglycemic agents; adjust dosing as needed. - Concurrent use with drugs that affect hepatic glycogen stores, such as corticosteroids. - Interaction with anesthetic agents during surgery; inform the anesthesia team. - When combined with diuretics, monitor electrolyte levels, especially potassium.